PMC:7346000 / 24509-24832 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"666","span":{"begin":164,"end":175},"obj":"Species"},{"id":"667","span":{"begin":299,"end":310},"obj":"Species"},{"id":"703","span":{"begin":92,"end":114},"obj":"Disease"}],"attributes":[{"id":"A666","pred":"tao:has_database_id","subj":"666","obj":"Tax:746128"},{"id":"A667","pred":"tao:has_database_id","subj":"667","obj":"Tax:746128"},{"id":"A703","pred":"tao:has_database_id","subj":"703","obj":"MESH:D055744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T204","span":{"begin":92,"end":114},"obj":"Disease"},{"id":"T205","span":{"begin":101,"end":114},"obj":"Disease"}],"attributes":[{"id":"A204","pred":"mondo_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A205","pred":"mondo_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T203","span":{"begin":147,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T204","span":{"begin":282,"end":290},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T171","span":{"begin":26,"end":39},"obj":"Chemical"},{"id":"T172","span":{"begin":136,"end":146},"obj":"Chemical"},{"id":"T173","span":{"begin":229,"end":233},"obj":"Chemical"},{"id":"T174","span":{"begin":234,"end":238},"obj":"Chemical"}],"attributes":[{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_57248"},{"id":"A172","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"},{"id":"A173","pred":"chebi_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A174","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T130","span":{"begin":0,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}

{"project":"2_test","denotations":[{"id":"32599813-31138565-60095156","span":{"begin":319,"end":321},"obj":"31138565"}],"text":"While currently available echinocandins are not considered first-line treatment options for invasive aspergillosis due to their limited antifungal activity against Aspergillus spp., they are generally well tolerated with limited drug–drug interactions and show at least fungistatic activity against Aspergillus hyphae [90]."}